Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site pain, Paraesthesia, Skin disorder
Clinical narrative: every pore on her skin looks like it has been pin pricked; burning sensation/episodes of hot,burning; redness feet and hands; numbness and tingling in her limbs/ all extremeties(feet, legs, hands, arm); numbness and tingling in her limbs/pins and needles sensation/ tingling in all extremeties(feet, legs, hands, arm); headache; soreness on the injection site; This spontaneous case was reported by a nurse and describes the occurrence of HYPOAESTHESIA (numbness and tingling in her limbs/ all extremeties(feet, legs, hands, arm)), BURNING SENSATION (burning sensation/episodes of hot,burning), SKIN DISORDER (every pore on her skin looks like it has been pin pricked), PARAESTHESIA (numbness and tingling in her limbs/pins and needles sensation/ tingling in all extremeties(feet, legs, hands, arm)) and ERYTHEMA (redness feet and hands) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 013M20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Tinnitus (it was constant) on 12-May-2021, Lumbar radiculopathy since an unknown date and Peripheral neuropathy (worsening) since 16-Jan-2021. Concurrent medical conditions included Chronic back pain (Flares on and off), Erythromelalgia (worsening) since 21-Jan-2021, Drug allergy (Gabapentin) and Drug allergy (steroids (oral and injection)). Concomitant products included LORAZEPAM (ATIVAN) from 12-Jan-2015 to an unknown date for Anxiety, NORTRIPTYLINE from 05-Jan-2002 to an unknown date for Depression.   On 15-Jan-2021 at 3:20 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021 at 2:15 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 15-Jan-2021, the patient experienced HEADACHE (headache) and INJECTION SITE PAIN (soreness on the injection site). On 16-Jan-2021, the patient experienced HYPOAESTHESIA (numbness and tingling in her limbs/ all extremeties(feet, legs, hands, arm)) and PARAESTHESIA (numbness and tingling in her limbs/pins and needles sensation/ tingling in all extremeties(feet, legs, hands, arm)). On 21-Jan-2021, the patient experienced BURNING SENSATION (burning sensation/episodes of hot,burning) and ERYTHEMA (redness feet and hands). On 23-Jan-2021, the patient experienced SKIN DISORDER (every pore on her skin looks like it has been pin pricked). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form and NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. On 15-Jan-2021, HEADACHE (headache) and INJECTION SITE PAIN (soreness on the injection site) had resolved. At the time of the report, HYPOAESTHESIA (numbness and tingling in her limbs/ all extremeties(feet, legs, hands, arm)), BURNING SENSATION (burning sensation/episodes of hot,burning), PARAESTHESIA (numbness and tingling in her limbs/pins and needles sensation/ tingling in all extremeties(feet, legs, hands, arm)) and ERYTHEMA (redness feet and hands) had not resolved and SKIN DISORDER (every pore on her skin looks like it has been pin pricked) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood test: normal (normal) normal. In 2021, Electromyogram: normal (normal) large fiber neuro-normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On an unknown date, patient have done COVOD-19 test twice.it was negative both times. The patient reported patient now have these symptoms on and off for over 5 months. They have been intermittent on all days. The patient has seen his medical provider via viedo appointment. She wanted to know if wants to know if there have been reports of Guillain Barre syndrome after the administration of the Moderna Covid-19 vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Significant follow up was received on the date 29-JUN-2021, reporter and patient details, lab data, medical history concomitant drugs, event terms, corrective treatment, events outcome were updated